Research Paper Volume 16, Issue 2 pp 1733—1749

Identification and validation of methylation-CpG prognostic signature for prognosis of hepatocellular carcinoma

class="figure-viewer-img"

Figure 2. Prognostic analysis of the HPSM subgroups. (A) Forest plot displaying the hazard ratios (HRs) for 4 CpGs and OS. (B) Kaplan-Meier survival curves for OS comparing HPSM-high group with HPSM-low group within the TCGA training dataset. (C) Kaplan-Meier survival curves for OS comparing HPSM-high group with HPSM-low group within the TCGA testing dataset. (D) Kaplan-Meier survival curves for OS comparing HPSM-high group with HPSM-low groups within the GSE52018 dataset. (E) ROC curves to predict the OS between HPSM groups within the TCGA training dataset. (F) ROC curves for OS prediction between HPSM groups within the TCGA testing dataset. (G) ROC curves for OS prediction between HPSM groups within the GSE52018 dataset.